Individual and joint impacts of ethanol use, BMI, age and gender on serum gamma-glutamyltransferase levels in healthy volunteers

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 11929-11941

  Danielsson, Joanna ^a   Kangastupa, Päivikki ^a   Laatikainen, Tiina ^b,c,d   Aalto, Mauri ^b,e   Niemelä, Onni ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d North Karelia Hospital   (Finland)

^e SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Ageing; Alcohol; Liver; Obesity; Oxidative stress

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; ENZYME ACTIVITY; FEMALE; FINLAND; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GLUTATHIONE METABOLISM; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; NORMAL HUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; SMOKING; VOLUNTEER; BLOOD; DRINKING BEHAVIOR; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; ETHANOL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 84878838095     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140611929     Document Type: Article

References (53)

1. Leon, D.A.; McCambridge, J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006, 367, 52-56.
2. Lieber, C.S. Medical disorders of alcoholism. N. Engl. J. Med. 1995, 333, 1058-1065.
3. Room, R.; Babor, T.; Rehm, J. Alcohol and public health. Lancet 2005, 365, 519-530.
4. Blachier, M.; Leleu, H.; Peck-Radosavljevic, M.; Valla, D.C.; Roudot-Thoraval, F. The burden of liver disease in Europe: A review of available epidemiological data. J. Hepatol. 2013, 58, 593-608.
5. Conway, B.; Rene, A. Obesity as a disease: No lightweight matter. Obes. Rev. 2004, 5, 145-151.
6. Korner, J.; Aronne, L.J. The emerging science of body weight regulation and its impact on obesity treatment. J. Clin. Invest. 2003, 111, 565-570.
7. Yu, Z.; Han, S.; Chu, J.; Xu, Z.; Zhu, C.; Guo, X. Trends in overweight and obesity among children and adolescents in China from 1981 to 2010: A meta-analysis. PLoS One 2012, 7, e51949.
8. Halsted, C.H. Obesity: Effects on the liver and gastrointestinal system. Curr. Opin. Clin. Nutr. Metab. Care 1999, 2, 425-429.
9. Ruhl, C.E.; Everhart, J.E. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin. Gastroenterol. Hepatol. 2005, 3, 1260-1268.
10. Lee, D.H.; Blomhoff, R.; Jacobs, D.R. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic. Res. 2004, 38, 535-539.
11. Zhang, H.; Forman, H.J. Redox regulation of gamma-glutamyl transpeptidase. Am. J. Respir. Cell Mol. Biol. 2009, 41, 509-515.
12. Kazemi-Shirazi, L.; Endler, G.; Winkler, S.; Schickbauer, T.; Wagner, O.; Marsik, C. Gamma glutamyltransferase and long-term survival: Is it just the liver? Clin. Chem. 2007, 53, 940-946.
13. Ruttmann, E.; Brant, L.J.; Concin, H.; Diem, G.; Rapp, K.; Ulmer, H. The Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112, 2130-2137.
14. Alatalo, P.I.; Koivisto, H.M.; Hietala, J.P.; Puukka, K.S.; Bloigu, R.; Niemelä, O.J. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am. J. Clin. Nutr. 2008, 88, 1097-1103.
15. Lee, D.H.; Ha, M.H.; Kam, S.; Chun, B.; Lee, J.; Song, K.; Boo, Y.; Steffen, L.; Jacobs, D.R. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am. J. Epidemiol. 2006, 163, 57-65.
16. Sillanaukee, P.; Massot, N.; Jousilahti, P.; Vartiainen, E.; Sundvall, J.; Olsson, U.; Poikolainen, K.; Pönniö, M.; Allen, J.P.; Alho, H. Dose response of laboratory markers to alcohol consumption in a general population. Am. J. Epidemiol. 2000, 152, 747-751.
17. Vartiainen, E.; Laatikainen, T.; Peltonen, M.; Juolevi, A.; Männistö, S.; Sundvall, J.; Jousilahti, P.; Salomaa, V.; Valsta, L.; Puska, P. Thirty-five-year trends in cardiovascular risk factors in Finland. Int. J. Epidemiol. 2010, 39, 504-518.
18. Puukka, K.; Hietala, J.; Koivisto, H.; Anttila, P.; Bloigu, R.; Niemelä, O. Age-related changes on serum GGT activity and the assessment of ethanol intake. Alcohol Alcohol. 2006, 41, 522-527.
19. Breitling, L.P.; Raum, E.; Müller, H.; Rothenbacher, D.; Brenner, H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009, 49, 802-808.
20. Tynjälä, J.; Kangastupa, P.; Laatikainen, T.; Aalto, M.; Niemelä, O. Effect of age and gender on the relationship between alcohol consumption and serum GGT: Time to recalibrate goals for normal ranges. Alcohol Alcohol. 2012, 47, 558-562.
21. Dey, A.; Cederbaum, A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43, S63-S74.
22. Sohal, R.S.; Weindruch, R. Oxidative stress, caloric restriction, and aging. Science 1996, 273, 59-63.
23. Loomba, R.; Bettencourt, R.; Barrett-Connor, E. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: The Rancho Bernardo Study. Aliment. Pharmacol. Ther. 2009, 30, 1137-1149.
24. Lee, D.H.; Buijsse, B.; Steffen, L.; Holtzman, J.; Luepker, R.; Jacobs, D.R. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: The Minnesota Heart Survey. Eur. J. Cardiovasc. Prev. Rehabil. 2009, 16, 16-20.
25. Montonen, J.; Boeing, H.; Schleicher, E.; Fritsche, A.; Pischon, T. Association of changes in body mass index during earlier adulthood and later adulthood with circulating obesity biomarker concentrations in middle-aged men and women. Diabetologia 2011, 54, 1676-1683.
26. Suter, P.M. Is alcohol consumption a risk factor for weight gain and obesity? Crit. Rev. Clin. Lab. Sci. 2005, 42, 197-227.
27. Tsukamoto, H.; Horne, W.; Kamimura, S.; Niemelä, O.; Parkkila, S.; Ylä-Herttuala, S.; Brittenham, G.M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 1995, 96, 620-630.
28. Lança, A.J.; Israel, Y. Histochemical demonstration of sinusoidal gamma-glutamyltransferase activity by substrate protection fixation: Comparative studies in rat and guinea pig liver. Hepatology 1991, 14, 857-863.
29. Speisky, H.; MacDonald, A.; Giles, G.; Orrego, H.; Israel, Y. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Turnover studies. Biochem. J. 1985, 225, 565-572.
30. Emdin, M.; Pompella, A.; Paolicchi, A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: Triggering oxidative stress within the plaque. Circulation 2005, 112, 2078-2080.
31. Fassett, R.G.; Venuthurupalli, S.K.; Gobe, G.C.; Coombes, J.S.; Cooper, M.A.; Hoy, W.E. Biomarkers in chronic kidney disease: A review. Kidney Int. 2011, 80, 806-821.
32. Mason, J.E.; Starke, R.D.; Van Kirk, J.E. Gamma-glutamyl transferase: A novel cardiovascular risk biomarker. Prev. Cardiol. 2010, 13, 36-41.
33. Ulmer, H.; Strohmaier, S.; Borena, W.; Edlinger, M.; Concin, H.; Diem, G.; Kelleher, C.; Nagel, G. P2-310 Gamma-glutamyltransferase as a biomarker for oxidative stress, metabolic syndrome, and alcohol consumption and its association with cancer incidence. J. Epidemiol. Commun. Health 2011, 65, A308.
34. Cardin, R.; Piciocchi, M.; Sinigaglia, A.; Lavezzo, E.; Bortolami, M.; Kotsafti, A.; Cillo, U.; Zanus, G.; Mescoli, C.; Rugge, M.; et al. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC. Cancer 2012, 12, 177.
35. Irie, M.; Sohda, T.; Iwata, K.; Kunimoto, H.; Fukunaga, A.; Kuno, S.; Yotsumoto, K.; Sakurai, K.; Iwashita, H.; Hirano, G.; et al. Levels of the oxidative stress marker gamma-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease. J. Int. Med. Res. 2012, 40, 924-933.
36. Marquez-Quiñones, A.; Cipak, A.; Zarkovic, K.; Fattel-Fazenda, S.; Villa-Treviño, S.; Waeg, G.; Zarkovic, N.; Guéraud, F. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic. Res. 2010, 44, 119-127.
37. Viitala, K.; Makkonen, K.; Israel, Y.; Lehtimäki, T.; Jaakkola, O.; Koivula, T.; Blake, J.E.; Niemelä, O. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin. Exp. Res. 2000, 24, 1103-1109.
38. Lee, D.H.; Jacobs, D.R.; Gross, M.; Kiefe, C.I.; Roseman, J.; Lewis, C.E.; Steffes, M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: The coronary artery risk development in young adults (CARDIA) study. Clin. Chem. 2003, 49, 1358-1366.
39. Lee, D.H.; Silventoinen, K.; Hu, G.; Jacobs, D.R.; Jousilahti, P.; Sundvall, J.; Tuomilehto, J. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur. Heart J. 2006, 27, 2170-2176.
40. Fentiman, I.S.; Allen, D.S. Gamma-glutamyl transferase and breast cancer risk. Br. J. Cancer 2010, 103, 90-93.
41. Franzini, M.; Paolicchi, A.; Fornaciari, I.; Ottaviano, V.; Fierabracci, V.; Maltinti, M.; Ripoli, A.; Zyw, L.; Scatena, F.; Passino, C.; et al. Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin. Chem. Lab. Med. 2010, 48, 713-717.
42. Franzini, M.; Fornaciari, I.; Rong, J.; Larson, M.G.; Passino, C.; Emdin, M.; Paolicchi, A.; Vasan, R.S. Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. Clin. Chim. Acta 2013, 417, 19-25.
43. Lippi, G.; Targher, G.; Montagnana, M.; Salvagno, G.L.; Guidi, G.C. Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. Clin. Chim. Acta 2007, 384, 163-166.
44. Strasak, A.M.; Pfeiffer, R.M.; Klenk, J.; Hilbe, W.; Oberaigner, W.; Gregory, M.; Concin, H.; Diem, G.; Pfeiffer, K.P.; Ruttmann, E.; et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int. J. Cancer 2008, 123, 1902-1906.
45. Willcox, J.K.; Ash, S.L.; Catignani, G.L. Antioxidants and prevention of chronic disease. Crit. Rev. Food Sci. Nutr. 2004, 44, 275-295.
46. Tsai, J.; Ford, E.S.; Zhao, G.; Croft, J.B. Multiple health behaviors and serum hepatic enzymes among US adults with obesity. Prev. Med. 2011, 53, 278-283.
47. Haring, R.; Wallaschofski, H.; Nauck, M.; Dorr, M.; Baumeister, S.E.; Volzke, H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009, 50, 1403-1411.
48. Day, C.P.; James, O.F. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998, 114, 842-845.
49. Diehl, A.M. Obesity and alcoholic liver disease. Alcohol 2004, 34, 81-87.
50. Kozakova, M.; Palombo, C.; Eng, M.P.; Dekker, J.; Flyvbjerg, A.; Mitrakou, A.; Gastaldelli, A.; Ferrannini, E.; RISC investigators. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 2012, 55, 1406-1415.
51. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA Project Principal Investigators. J. Clin. Epidemiol. 1988, 41, 105-114.
52. Tolonen, H.; Kuulasmaa, K.; Laatikainen, T.; Wolf, H. The European Health Risk Monitoring Project. Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys, 2002. Available online: http://www.thl.fi/publications/ehrm/product2/title.htm (accessed on 2 April 2013).
53. Leino, A.; Impivaara, O.; Irjala, K.; Mäki, J.; Peltola, O.; Järvisalo, J. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand. J. Clin. Lab. Invest. 1995, 55, 243-250.